147 related articles for article (PubMed ID: 10584879)
1. Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells.
Dhar KK; Branigan K; Parkes J; Howells RE; Hand P; Musgrove C; Strange RC; Fryer AA; Redman CW; Hoban PR
Br J Cancer; 1999 Dec; 81(7):1174-81. PubMed ID: 10584879
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors.
Hibberts NA; Simpson DJ; Bicknell JE; Broome JC; Hoban PR; Clayton RN; Farrell WE
Clin Cancer Res; 1999 Aug; 5(8):2133-9. PubMed ID: 10473097
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck.
Akervall J; Borg A; Dictor M; Jin C; Jin Y; Tanner M; Isola J; Mertens F; Wennerberg J
Int J Oncol; 2002 Jan; 20(1):45-52. PubMed ID: 11743641
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival.
Ratschiller D; Heighway J; Gugger M; Kappeler A; Pirnia F; Schmid RA; Borner MM; Betticher DC
J Clin Oncol; 2003 Jun; 21(11):2085-93. PubMed ID: 12775733
[TBL] [Abstract][Full Text] [Related]
6. Significance of beta-catenin and pRB pathway components in malignant ovarian germ cell tumours: INK4A promoter CpG island methylation is associated with cell proliferation.
Kawauchi S; Liu XP; Kawasaki K; Hirakawa T; Amada S; Furuya T; Oga A; Sasaki K
J Pathol; 2004 Nov; 204(3):268-76. PubMed ID: 15476271
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
8. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 gene (CCND1) mutations in endometrial cancer.
Moreno-Bueno G; Rodríguez-Perales S; Sánchez-Estévez C; Hardisson D; Sarrió D; Prat J; Cigudosa JC; Matias-Guiu X; Palacios J
Oncogene; 2003 Sep; 22(38):6115-8. PubMed ID: 12955092
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
[TBL] [Abstract][Full Text] [Related]
11. beta-Catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression.
Shiratsuchi H; Nakashima T; Hirakawa N; Toh S; Nakagawa T; Saito T; Tsuneyoshi M; Komune S
Head Neck; 2007 Jun; 29(6):577-84. PubMed ID: 17315172
[TBL] [Abstract][Full Text] [Related]
12. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer.
Wagner U; Süess K; Luginbühl T; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Jordan P; Moch H; Mihatsch MJ; Gasser TC; Sauter G
J Pathol; 1999 May; 188(1):44-50. PubMed ID: 10398139
[TBL] [Abstract][Full Text] [Related]
14. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
16. 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization.
Diebold J; Mösinger K; Peiro G; Pannekamp U; Kaltz C; Baretton GB; Meier W; Löhrs U
J Pathol; 2000 Apr; 190(5):564-71. PubMed ID: 10727982
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.
Gautschi O; Ratschiller D; Gugger M; Betticher DC; Heighway J
Lung Cancer; 2007 Jan; 55(1):1-14. PubMed ID: 17070615
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer.
Barbieri F; Lorenzi P; Ragni N; Schettini G; Bruzzo C; Pedullà F; Alama A
Oncology; 2004; 66(4):310-5. PubMed ID: 15218299
[TBL] [Abstract][Full Text] [Related]
19. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
Naidu R; Wahab NA; Yadav MM; Kutty MK
Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
[TBL] [Abstract][Full Text] [Related]
20. Paget's disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1.
Mrhalova M; Kodet R
Neoplasma; 2003; 50(6):396-402. PubMed ID: 14689059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
